McDavid Stilwell - Apr 1, 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Financial Officer
Signature
/s/ McDavid Stilwell
Stock symbol
CHRS
Transactions as of
Apr 1, 2022
Transactions value $
-$44,435
Form type
4
Date filed
4/5/2022, 05:19 PM
Previous filing
Jan 6, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability -$44.4K -3.46K -4.73% $12.85 69.7K Apr 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.